Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Acupuncture to Reduce Chemotherapy Induced Peripheral Neuropathy (CIPN) in Gynaecological Cancer Patients - A Pilot Randomised Controlled Trial

NCT06769061 is registered in ClinicalTrials.gov with Karen Kar Loen CHAN as lead sponsor.

NCT NCT06769061
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06769061 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Acupuncture to Reduce Chemotherapy Induced Peripheral Neuropathy (CIPN) in Gynaecological Cancer Patients - A Pilot Randomised Controlled Trial
Lead sponsor
Karen Kar Loen CHAN
Phase
Not applicable
Overall status
Recruiting
Start date
February 12, 2025
Completion date
December 31, 2027
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acupuncture, chemotherapy-induced peripheral neuropathy, gynaecological, urological or rectal cancer